The PSC Category AN11 encompasses Health Research and Development Services, Health Care Services, and Basic Research. This category includes a wide range of scientific and medical research activities, focusing on advancing medical knowledge, developing new healthcare technologies, and conducting fundamental scientific investigations. The services span multiple domains including clinical trials, laboratory research, medical device development, epidemiological studies, and innovative healthcare solutions across various medical disciplines. Federal Contract Awards in this category demonstrate significant investment in medical research, with contract values ranging from $10,000 to over $9 million. Key funding agencies include the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), and National Institute on Drug Abuse (NIDA). Frequently awarded entities include research universities like the University of Michigan, Stanford University, and Northwestern University, as well as specialized research organizations such as Charles River Laboratories and Alpha Genesis Inc. Most awards are not set-aside, though some utilize small business or 8(a) designations. Typical contract types include delivery orders, definitive contracts, and purchase orders, with performance periods ranging from 6 months to 7 years. Recent Federal Contract Opportunities within PSC AN11 focus on advanced medical research initiatives, including the establishment of research networks, development of diagnostic technologies, and conducting specialized clinical trials. Key opportunities include the NIH NeuroBioBank Brain and Tissue Repository, NIAID's In Vitro Assessments of Antimicrobial Activity, and the Best Pharmaceuticals for Children Act Pediatric Trials Network. Requested services encompass genetic sequencing, drug development, clinical research support, and innovative medical technologies. Federal agencies driving these opportunities include NIH, Centers for Disease Control and Prevention (CDC), and Department of Veterans Affairs. Performance locations are predominantly within the United States, with a strong emphasis on academic and research institution facilities.
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Last Date To Order (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
75FCMC23D0004 | The Mitre Corporation | $2.0b | 9/26/23 | 9/24/28 | 6/4/24 | |
75D30121D12750 | The Johns Hopkins University | $99.0m | 9/30/21 | 9/29/26 | 9/27/21 | |
75N92019D00017 | Lovelace Biomedical Research Institute | $13.3m | 12/19/18 | 6/18/25 | 6/14/24 | |
75N95021D00023 | Booz Allen Hamilton Inc. | $47.0m | 9/17/21 | 9/16/26 | 12/17/24 | |
75N95018D00023 | Rutgers, The State University | $19.7m | 9/19/18 | 9/20/22 | 2/15/24 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 75D30121D12750-75D30122F00001 | The Johns Hopkins University | $1.7m | 9/15/22 | 6/14/24 | 3/11/24 | |
Delivery Order 75N92019D00017-75N92020F00001 | Lovelace Biomedical Research Institute | $352.5k | 6/8/20 | 11/19/21 | 5/18/23 | |
Delivery Order 75FCMC23D0004-HT942524F0204 | The Mitre Corporation | $1.9m | 6/17/24 | 6/16/27 | 6/14/24 | |
Delivery Order 75N95021D00023-75N95021F00001 | Booz Allen Hamilton Inc. | $3.1m | 9/17/21 | 9/16/22 | 9/15/21 | |
Delivery Order 75N95018D00023-75N95021F00001 | Rutgers, The State University | $2.5m | 4/5/21 | 3/13/22 | 4/2/21 |
A Portfolio Platform of GovExec © 2025